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Abstract
Fibrous structures mimicking the morphology of the natural extracellular matrix are considered
promising scaffolds for tissue engineering. This work aims to develop a novel hierarchical
starch-based scaffold. Such scaffolds were obtained by a combination of starch–polycaprolactone
micro- and polycaprolactone nano-motifs, respectively produced by rapid prototyping (RP) and
electrospinning techniques. Scanning electron microscopy (SEM) and micro-computed tomography
analysis showed the successful fabrication of a multilayer scaffold composed of parallel aligned
microfibres in a grid-like arrangement, intercalated by a mesh-like structure with randomly
distributed nanofibres (NFM). Human osteoblast-like cells were dynamically seeded on the scaffolds,
using spinner flasks, and cultured for 7 days under static conditions. SEM analysis showed
predominant cell attachment and spreading on the nanofibre meshes, which enhanced cell retention
at the bulk of the composed/hierarchical scaffolds. A significant increment in cell proliferation
and osteoblastic activity, assessed by alkaline phosphatase quantification, was observed on the
hierarchical fibrous scaffolds. These results support our hypothesis that the integration of nanoscale
fibres into 3D rapid prototype scaffolds substantially improves their biological performance in bone
tissue-engineering strategies. Copyright  2008 John Wiley & Sons, Ltd.
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1. Introduction
Biodegradable scaffolds are generally recognized as
indispensable elements in tissue engineering and regen-
erative medicine strategies. Scaffolds are used as tempo-
rary templates for cell seeding, migration, proliferation
and differentiation prior to the regeneration of biolog-
ically functional tissue or natural extracellular matrix
(ECM) (Lutolf and Hubbell, 2005; Hutmacher et al.,
2007). Ideally, to create a tissue-engineered construct
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capable of regenerating a fully functional tissue, it
should mimic both the fibrous form and the com-
plex function of the native ECM (Agrawal and Ray,
2001). Like natural ECM, a range of topographic fea-
tures at the macro-, micro- and even nano-scale levels
must lead cell response (Norman and Desai, 2006).
A multi-scale network structure can be developed by
integrating microfibrous structures, produced by wet-
spinning or rapid prototyping, with electrospun nanofi-
bres (Tuzlakoglu et al., 2005; Santos et al., 2007; Moroni
et al., 2008).
Electrospun fibres typically have dimensions varying
from the nano- to the micro-scale, although fibre
diameters in the sub-micrometer range are mainly
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observed (Huang et al., 2003). These mesh-like scaffold
are characterized by high porosity, high surface : volume
ratio and, most importantly, they can closely mimic the
morphology of the native ECM of many tissues. Such
physical cues enhance cell adhesion, proliferation and
differentiation, and consequently neo-tissue formation
on nanofibrous meshes of both natural and synthetic
polymers (Zhang et al., 2005; Martins et al., 2007).
Rapid prototyping has emerged as a powerful polymer-
processing technique for the production of scaffolds in
the area of tissue engineering (Hutmacher et al., 2004;
Leong et al., 2003; Mironov et al., 2003; Peltola et al.,
2008; Pfister et al., 2004; Yang et al., 2002; Yeong et al.,
2004). The main advantage of this technique is the
possibility of creating structures with customized shapes
linked with computer-aided design (CAD), thus providing
more flexibility, versatility and reproducibility in creating
scaffolds (Hutmacher et al., 2004; Moroni et al., 2005;
Moroni et al., 2006; Capes et al., 2005). However, the
typical pore size of RP scaffold constitutes a limitation in
the cell-seeding efficiency (Pfister et al., 2004), once it is
relatively large as compared to cell dimensions.
Therefore, the aim of this study was to character-
ize a novel hierarchical starch-based fibrous scaffold
obtained by the combination of starch–polycaprolactone
(SPCL) micro- and polycaprolactone (PCL) nano-motifs,
respectively produced by rapid prototyping (RP) and elec-
trospinning. The defined strategy aimed at overcoming
the high number of cells needed to attain sufficient adher-
ent cells to the RP scaffolds (Moroni et al., 2008), which
can be accomplished by alternately integrating electro-
spun nanofibre meshes every two consecutive layers of
plotted microfibres. In this way these nanofibre meshes
will act as cell entrapment systems, increasing cell attach-
ment efficiency, cell proliferation and tissue regeneration.
Ultimately, this integration will enhance the potential
application of such three-dimensional (3D) fibrous struc-
tures in bone tissue-engineering strategies. This work
reports the results of a set of experiments in which human
osteoblast-like cells were dynamically seeded and stati-
cally cultured for 7 days on micro-nano fibre polymeric
scaffolds designed to validate this hypothesis.
2. Materials and methods
2.1. Scaffold fabrication
Three-dimensional (3D) rapid prototyping scaffolds (6RP)
were fabricated using a 3D plotting technique (Bio-plotter,
EnvisionTec GmbH, Germany), using a 30 : 70 (wt%)
blend of starch and polycaprolactone (SPCL, Novamont,
Italy). SPCL polymer powder was placed into a metal
barrel and heated at 140 ◦C through a heated cartridge
unit, then plotted through a nozzle by air pressure
control. The nozzle comprises a stainless steel needle
with internal diameter 0.5 mm and length 6 mm. A metal
piston plunger with a Teflon seal was used to apply
pressure to the molten polymer. The machine was linked
to CAD software (PrimCam, Germany) which required
inputs of dispensing and processing parameters (e.g.
speed of the head, dispensing pressure and temperature)
and the design parameters of the scaffold (e.g. scaffold
dimensions, spacing between the polymer strands, and
number of layers). The strand spacing was set to
1 mm, without offsets between the consecutive equivalent
layers. The orientation was changed by plotting the
polymer with 90◦ angle steps between two successive
layers. The production of hierarchical fibrous scaffolds
(6RP + 5NFM) was achieved by integrating nanofibre
meshes (NFM) every two consecutive layers of plotted
microfibres. The nanofibre meshes were previously
produced by electrospinning, as described elsewhere
(Araujo et al., 2007). Briefly, a polymeric solution of
17% w/v PCL, dissolved in an organic solvent mixture
of chloroform : dimethylformamide (7 : 3 ratio), was
electrospun by establishing a electric tension of 9.5 kV, a
needle tip-to-ground collector distance of 200 mm and a
flow rate of 1 ml/h. The scaffolds (6RP and 6RP + 5NFM
scaffolds) were all cut into 5 × 5 mm cubical samples
from the originally deposited bulk 20 × 20 mm cube (12
layers) and sterilized using ethylene oxide (EtO) before
the cell culture assays.
2.2. Scaffold characterization
Scaffold architecture was analysed using micro-computed
tomography (µ-CT) with a desktop micro CT scanner
(SkyScan 1072, Aartselaar, Belgium). The scanner was
set to a voltage of 40 kV and a current of 248 µA, and
the samples were scanned at 8.71 µm pixel resolutions
by approximately 350 slices covering the sample height
of 2.5 mm. For imaging, the sliced 2D tomographic raw
images were reconstructed using CT Analyser software,
and the threshold levels of the greyscale images were
equally adjusted for all the samples to allow the
measurement of the volume of pores, providing the data
for scaffold porosity. 3D modelling was also used to
analyse the scaffold structure in a non-destructive manner,
using imaging software. The morphology of the scaffold
was also analysed, using scanning electron microscopy
(SEM; Leica Cambridge, Model S360, UK). All samples
were previously sputter-coated with gold (Sputter Coater,
Model SC502, Fisons Instruments, UK).
2.3. Cell seeding and culture
Human osteosarcoma-derived cells [Saos-2 cell line,
European Collection of Cell Cultures (ECACC), UK],
were maintained in Dulbecco’s modified Eagle’s medium
(DMEM; Sigma-Aldrich; Germany) supplemented with
10% heat-inactivated fetal bovine serum (Biochrom AG,
Berlin, Germany) and 1% antibiotic–antimycotic solution
(Gibco, UK). Cells were cultured in a humidified incubator
at 37 ◦C in a 5% CO2 atmosphere and the medium was
routinely replaced every 3–4 days.
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Confluent osteoblastic-like cells were harvested and
dynamically seeded onto the polymeric scaffolds as
follows. The combined and the RP (controls) scaffolding
structures were placed between stainless steel holding
wires in spinner flasks (12 scaffolds/spinner flask)
containing a suspension of osteoblast-like cells with a
concentration of 0.5 × 106 cells/ml in a total volume
of 35 ml. The stirrer was set at 80 r.p.m. and the
spinner flasks left on for 72 h to allow the cells to
colonize the entire scaffold. After this time period the
osteoblasts/scaffold constructs were transferred to 24-
well cell culture plates (Costar, Corning, NY, USA) and
statically cultured for 1 and 7 days under the culture
conditions previously described for maintenance of the
cell line.
2.4. Evaluation of cell adhesion, morphology
and distribution
To evaluate the cell morphology, the cells–scaffold
constructs were fixed with 2.5% glutaraldehyde (Sigma,
USA) in phosphate-buffered saline (PBS; Sigma) solution
for 1 h at 4 ◦C. Then, the samples were dehydrated
through a graded series of ethanol and allowed to dry
overnight. Finally, they were sputter-coated with gold
(Model SC502, Fisons Instruments, UK) and observed
in a scanning electron microscope (Model S360, Leica
Cambridge, UK).
2.5. Cell viability assay
At each defined time culture period, the cell via-
bility was determined using the CellTiter 96 Aque-
ous One Solution Cell Proliferation Assay (Promega,
USA). This assay is based on the bioreduction of
a tetrazolium compound, 3-(4,5-dimethylthiazol-2-yl)-5-
(3-carboxymethoxyphenyl)-2-(4-sulphofenyl)-2H-tetra-
zolium (MTS), into a water-soluble brown formazan prod-
uct. This conversion is accomplished by NADPH or NADH
production by the dehydrogenase enzymes in metaboli-
cally active cells. The absorbance, measured at 490 nm
in a microplate reader (Bio-Tek, Synergie HT, USA), is
related to the quantity of formazan product and directly
proportional to the number of living cells in the con-
structs. Three samples per type of scaffold and per time
point were characterized.
2.6. DNA Quantification
Cell proliferation was evaluated by quantifying the total
amount of double-stranded DNA throughout the culture
time. Quantification was performed using the Quant-
iT PicoGreen dsDNA Assay Kit (Invitrogen, Molecular
Probes, OR, USA), according to the manufacturer’s
instructions, and after the cells in the construct were
lysed by osmotic and thermal shock. The intensity of
the fluorescence, proportional to the amount of double-
strand DNA, was measured at an excitation wavelength of
485/20 nm and at an emission wavelength of 528/20 nm,
in a microplate reader (Bio-Tek, Synergie HT, USA).
Triplicates of each sample, allowed for a statistical
analysis. The DNA concentration for each sample was
calculated using a standard curve relating quantity of
DNA and fluorescence intensity.
2.7. Alkaline phosphatase (ALP) quantification
To assess the osteogenic activity of cells seeded into the
3D scaffolds (6RP and 6RP + 5NFM), the expression of
ALP was determined for both culture time periods, in the
same samples used for DNA quantification. In each well
of a 96-well plate (Costar, Corning, NY, USA), 20 µl
of each sample were mixed with 60 µl substrate solution
and 0.2% wt/v p-nytrophenyl phosphate (Sigma, USA),
in a substrate buffer of 1 M diethanolamine HCl (Merck,
Germany) at pH 9.8. The plate was then incubated in
the dark for 45 min at 37 ◦C. After the incubation period,
80 µl stop solution, 2 M NaOH (Panreac; Barcelona, Spain)
plus 0.2 mM EDTA (Sigma), was added to each well.
Standards were prepared with 10 µM/ml p-nytrophenol
(pNP, Sigma, USA) solution, to obtain a standard curve
covering the range 0–0.3 µM/ml. Triplicates of each
sample and standard were made. Absorbance was read at
405 nm in a microplate reader (Bio-Tek, Synergie HT) and
sample concentrations were read off from the standard
curve. These ALP concentrations were normalized against
the DNA concentrations of the same samples to determine
the ALP activity.
2.8. Statistical analysis
Statistical analysis was performed using the SPSS
statistic software (release 8.0.0 for Windows). First, a
Shapiro–Wilk test was used to ascertain about data
normality. Once biological results did not follow a
normal distribution, Kruskal–Wallis test was performed
to compare the effect of scaffold architecture over cell
performance. In the analysis of the results, p < 0.05 was
considered statistically significant.
3. Results and discussion
A novel hierarchical fibrous scaffold was developed,
combining starch–polycaprolactone micro- and poly-
caprolactone nano-motifs, respectively produced by rapid
prototyping (RP) and electrospinning (ES). These scaf-
folds were characterized by a 3D structure of parallel
aligned rapid prototyped microfibres (average fibre diam-
eter, 300 µm), periodically intercalated by randomly
distributed electrospun nanofibres (fibre diameters in
the range 400 nm–1.4 µm) (Figure 1B). When nanofi-
bre meshes were integrated within the 3D scaffold, no
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Figure 1. SEM and µ-CT micrographs of the starch-based rapid prototyped, 6RP (A, C) and hierarchical fibrous scaffolds, 6RP +
5NFM (B, D)
delamination between consecutive layers of RP fibres
was observed, resulting in a stable scaffold. Addition-
ally, this micro–nano scaffold architecture comprises a
high-throughput scaffold process methodology, with reg-
ular control over RP-produced structure and nanofibres
distribution within the scaffold. The integration of these
nano-motifs resulted in a decrease of scaffold porosity of
around 11% (from 79.4% on 6RP scaffolds to 68.3% on
6RP + 5NFM scaffolds), as determined by µ-CT analysis
(Figure 1C, D). Despite a decrease in porosity, a fully inter-
connected porous structure was observed, allowing gas,
nutrient and waste transport through the 3D structure.
Starch-based scaffolds have been proposed as candi-
dates for bone tissue-engineering strategies in multiple
studies (Gomes et al., 2001, 2003, 2006, 2008; Salgado
et al., 2004, Salgado et al., 2005, 2007; Tuzlakoglu et al.,
2005), supporting the choice of SPCL to develop the struc-
tures proposed in this study. Indeed, successful results
were demonstrated in terms of cell viability, prolifera-
tion and maturation of osteoblastic cells or differentiation
of bone marrow stromal cells. Moreover, other starch-
based blends (corn starch, dextran and gelatine, 50 : 30:20
wt%) have already been used to produce different scaf-
fold designs by 3D printing (3DP) (Lam et al., 2002).
Although showing suitable physicochemical properties
for tissue-engineering applications, the biocompatibility
of those 3DP geometric scaffolds, with a highly inter-
connected porous network, remains to be tested. The
hierarchical starch-based fibrous scaffolds developed in
the present study were seeded with human osteoblast-
like cells to observe how the scaffold architecture affects
their behaviour. Cells were initially allowed to attach to
the scaffold using a dynamic system; this spinner flask
bioreactor allows the cells to efficiently penetrate into the
inner regions of the scaffolds, avoiding in a certain extent
the preferential colonization of the outer most parts of the
scaffolds (Oliveira et al., 2007). Consequently, a homoge-
neous distribution of cells throughout the entire scaffold
was observed. However, SEM micrographs demonstrated
that osteoblastic cells preferentially adhered to the nanofi-
brous meshes (Figure 2B, D, G, H). This phenomenon of
cellular preference was previously described by our group
and others (Tuzlakoglu et al., 2005, Kwon et al., 2005,
Yang et al., 2005), when different cell types (osteoblas-
tic, endothelial and neural stem cells) were seeded in
micro- and nano-fibre-based scaffolds. Additionally, the
integration of nanofibre meshes into the 3D rapid proto-
typed scaffolds seemed to act as a cell entrapment system
within the RP scaffold. It was reported by others (Pfis-
ter et al., 2004) that cells go through the pores of rapid
prototyped scaffolds and accumulate at the bottom of the
well plate during the seeding process, without attaching
the scaffold, and thus reducing the seeding efficiency typ-
ically down to values of 25–35%. Thus, the integration
of nanofibre meshes constitutes an innovative strategy to
enhance cell seeding efficiency into 3D RP scaffolds.
The quantification of cell viability and metabolic
activity of human osteoblast-like cells seeded into
the combined electrospun nanofiber meshes and RP
scaffolds was evaluated by MTS assay (Figure 3). The
results revealed a steadily increasing trend, with culture
time, although there was no significant difference
on the effect of the type of scaffold architectures
(p > 0.05). From the morphological evaluation of the
constructs, it seems that the integrated nanofibre
meshes into the 3D rapid prototyped structure also
acted as a cell entrapment system within the scaffold.
Consequently, a significant increment of cell proliferation
and maturation, respectively assessed by DNA and
ALP activity quantification, along the culture time, was
observed on the hierarchical fibrous scaffolds (Figures 4,
5) in comparison to the rapid prototyped scaffolds (p <
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Figure 2. SEM micrographs of rapid prototyped (A, C, E, G) and hierarchical fibrous (B, D, F, H) scaffolds cultured with human
osteoblast-like cells (Saos-2 cell line) for 1 (A–D) and 7 (E–H) days. Cross-sections (A, B, E, F) and top views (C, D, G, H) of the
constructs. Insets, higher magnifications
Figure 3. Box plot of cell viability results of human osteoblastic
cells cultured on rapid prototyped (6RP) and hierarchical fibrous
(6RP + 5NFM) scaffolds for 1 and 7 days. Data were analysed by
the non-parametric method of a Kruskal–Wallis test (p < 0.05)
Figure 4. Box plot of DNA content of osteoblast-like cells
cultured on rapid prototyped (6RP) and hierarchical fibrous
(6RP + 5NFM) scaffolds for 1 and 7 days. Data were analysed by
the non-parametric method of a Kruskal–Wallis test; ∗p < 0.05
0.05), especially for longer culture periods. However,
for the RP scaffolds, the osteoblastic activity was not
maintained throughout the experiment, as observed by a
Figure 5. Box plot of ALP activity, normalized against dsDNA
amount, from osteoblastic cells (Saos-2 cell line) cultured
on rapid prototyped (6RP) and hierarchical fibrous (6RP +
5NFM) scaffolds for 1 and 7 days. Data were analysed by the
non-parametric method of a Kruskal–Wallis test; ∗p < 0.05
decrease in ALP activity from day 1 to day 7 of culture.
It was previously reported by Schantz et al. (2003) that
rabbit calvarial osteoblasts, seeded onto PCL scaffolds
fabricated via fused deposition modelling (FDM) and
embedded into a fibrin matrix (Tisseel, Baxter Hyland
Immuno), showed no significant differences in their ALP
activity along time. These results are in accordance with
those of our study.
4. Conclusion
A novel hierarchical fibrous scaffold was developed,
combining starch-polycaprolactone micro- and polycapro-
lactone nano-motifs, respectively produced by rapid
prototyping and electrospinning. It is evident that the
nanofiber meshes supply topological cues at the ECM
level, whereas the micro 3D fibrous structure provide
the required mechanical stability. We here demonstrated
that the integration of these two hierarchial structures
lead to improved biological performance. Indeed, human
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osteoblast-like cells presented significantly higher prolif-
eration and maturation when seeded on these hierarchical
starch-based fibrous scaffolds. Overall, the results corrob-
orate our hypothesis that the hierarchical fibrous structure
of the scaffolds, mimicking the hierarchical structure of
the native ECM, is favourable for bone tissue-engineering
strategies.
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